The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells

Anti-Cancer Drugs

Volumn 17, Issue 3, 2006, Pages 297-305

  Tang, Li ^a   Li, Guolin ^a   Song, Liguo ^a   Zhang, Yuesheng ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Anti cancer agent; Isothiocyanate; N acetylcysteine conjugate; Urinary bladder cancer

Indexed keywords

ACETYLCYSTEINE; ISOTHIOCYANIC ACID DERIVATIVE;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DIET; GROWTH INHIBITION; HUMAN; HUMAN CELL; METABOLITE; PHYTOCHEMISTRY; PRIORITY JOURNAL; URINE; VEGETABLE;

ACETYLCYSTEINE; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOTHIOCYANATES; THIOCYANATES; URINARY BLADDER NEOPLASMS;

EID: 33646087882     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200603000-00008     Document Type: Article

References (58)

1. Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, et al. Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2001; 10:1063-1067.
2. Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, et al. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res 2003; 63:3980-3986.
3. Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese health study. Carcinogenesis 2002; 23:2055-2061.
4. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 1999; 91:605-613.
5. Zhang Y, Talalay P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 1994; 54 (Suppl):1976s-1981s.
6. Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem 1995; 22 (Suppl):195-209.
7. Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 2000;32:395-411.
8. Conaway CC, Yang YM, Chung FL. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002; 3:233-255.
9. IARC. IARC handbook of cancer prevention 6: cruciferous vegetables, isothiocyanates and indoles. Lyon: IARC Press; 2004.
10. Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001; 56:5-51.
11. Fenwick GR, Heaney RK, Mullin WJ. Glucosinolates and their breakdown products in food and food plants. Crit Rev Food Sci Nutr 1983; 18: 123-201.
12. Rabot S, Nugon-Baudon L, Raibaud P, Szylit O. Rape-seed meal toxicity in gnotobiotic rats: influence of a whole human faecal flora or single human strains of Escherichia coli and Bacteroides vulgatus. Br J Nutr 1993; 70:323-331.
13. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomark Prev 1998; 7:1091-1100.
14. Getahun SM, Chung F-L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol Biomark Prev 1999; 8:447-451.
15. Zhang Y, Tang L, Gonzalez V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther 2003; 2:1045-1052.
16. Tang L, Zhang Y. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab 2004; 5:193-201.
17. Mennicke WH, Gorler K, Krumbiegel G, Lorenz D, Rittmann N. Studies on the metabolism and excretion of benzyl isothiocyanate in man. Xenobiotica 1988; 18:39-47.
18. Jiao D, Ho CT, Fioles P, Chung FL. Identification and quantification of the N-acetylcysteine conjugate of allyl isothiocyanate in human urine after ingestion of mustard. Cancer Epidemiol Biomarkers Prev 1994; 3: 487-492.
19. Juffs HG, Moore MJ, Tannock IF. The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. Lancet Oncol 2002; 3:738-747.
20. Bollard M, Stribbling S, Mitchell S, Caldwell J. The disposition of allyl isothiocyanate in the rat and mouse. Food Chem Toxicol 1997; 35: 933-943.
21. Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 2002; 20:631-636.
22. Yang YM, Jhanwar-Uniyal M, Schwartz J, Conaway CC, Halicka HD, Traganos F, et al. N-acetylcysteine conjugate of phenethyl isothiocyanate enhances apoptosis in growth-stimulated human lung cells. Cancer Res 2005; 65:9538-9547.
23. Yang YM, Conaway CC, Chiao JW, Wang CX, Amin A, Whysner J, et al. Inhibition of benzo[a]pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res 2002; 62:2-7.
24. Jiao D, Smith TJ, Yang CS, Pittman B, Desai D, Amin S, et al. Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis 1997; 18:2143-2147.
25. Chung FL, Conaway CC, Rao CV, Reddy BS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000; 21:2287-2291.
26. Conaway CC, Wang C-X, Pittman B, Yang Y-M, Schwartz JE, Tian D, et al. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 2005; 65:8548-8557.
27. Metts MC, Metts JC, Milito SJ, Thomas Jr CR. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000; 92:285-294.
28. Colquhoun AJ, Mellon JK. Epidermal growth factor receptor and bladder cancer. Postgrad Med J 2002; 78:584-589.
29. Lamm DL, Griffith JG. Intravesical therapy: does it affect the natural history of bladder cancer? Semin Urol 1992; 10:39-44.
30. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer:an analysis of 315 cases. J Urol 1982; 127:250-252.
31. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumours (stages pTa, grade 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986; 135:920-922.
32. Braud F, Maffezzini M, Vitale V, Bruzzi P, Gatta G, Hendry WF, et al. Bladder cancer. Crit Rev Oncol Hematol 2002; 41:89-106.
33. Ries LAG, Eisner MP, Kosary CL, Hanker BF, Miller BA, Clegg L, et al. (editors). SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute; 2000.
34. Department of Health and Human Services, National Center for Health Statistics. Health, United States, 2001, with urban and rural health chartbook. Hyattsville: DHHS; 2001.
35. Tang L, Zhang Y. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 2004; 134:2004-2010.
36. Shinohara N, Liebert M, Wedemeyer G, Chang JHC, Grossman HB. Evaluation of multiple drug resistance in human bladder cancer cell lines. J Urol 1993; 150:505-509.
37. Vermeulen M, van Rooijen HJM, Vaes WHJ. Analysis of isothiocyanate mecapturic acids in urine: a biomarker for cruciferous vegetable intake. J Agric Food Chem 2003; 51:3554-3559.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
39. Zhang Y, Wade KL, Prestera T, Talalay P. Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation with 1,2-benzenedithiol. Anal Biochem 1996; 239:160-167.
40. Zhang Y, Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res 1998; 58:4632-4639.
41. Tang L, Zhang Y. Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther 2005; 4:1250-1259.
42. Dressler LG, Bartow SA. DNA flow cytometry in solid tumors: practical aspects and clinical applications. Semin Diagn Pathol 1989; 6:55-82.
43. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002; 62:6973-6980.
44. Zhang Y. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 2000; 21:1175-1182.
45. Zhang Y. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 2001; 22:425-431.
46. Conaway CC, Krzeminski J, Amin S, Chung FL. Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chem Res Toxicol 2001; 14:1170-1176.
47. Donzelli M, Draetta GF. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 2003; 4:671-677.
48. Gamet-Payrastre L, Lumeau S, Gasc N, Cassar G, Rollin P, Tulliez J. Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs 1998; 9:141-148.
49. Musk SRR, Johnson IT. Allyl isothiocyanate is selectively toxic to transformed cells of the human colorectal tumour line HT-29. Carcinogenesis 1993; 14:2079-2083.
50. 2/M arrest and inducing apoptosis. Carcinogenesis 2003; 24:891-897.
51. Choi S, Singh SV. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res 2005; 65:2035-2043.
52. Kassahun K, Davis M, Hu P, Martin B, Baillie T. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem Res Toxicol 1997; 10:1228-1233.
53. Baillie TA, Slatter JG. Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo. Acc Chem Res 1991; 24:264-270.
54. Bruggeman IM, Temmink HM, van Bladeren PJ. Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate. Toxicol Appl Pharmacol 1986; 83:349-359.
55. 2/M boundary by modulating the kinetics of activation and the subcellular localization of Cdc25C phosphatase. J Cell Physiol 2005; 205:310-318.
56. 2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol Cancer Ther 2004; 3:567-575.
57. Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 2005; 26:1978-1987.
58. 2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 2004; 279:25813-25822.